These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1846552

  • 1. Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.
    Cunningham JM, Francis GE, Holland MJ, Pirollo KF, Chang EH.
    Br J Cancer; 1991 Jan; 63(1):29-36. PubMed ID: 1846552
    [Abstract] [Full Text] [Related]

  • 2. A defect in DNA topoisomerase II activity in ataxia-telangiectasia cells.
    Mohamed R, Pal Singh S, Kumar S, Lavin MF.
    Biochem Biophys Res Commun; 1987 Nov 30; 149(1):233-8. PubMed ID: 2825700
    [Abstract] [Full Text] [Related]

  • 3. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE, Adachi K, Morgan AR.
    Mol Pharmacol; 1991 Oct 30; 40(4):495-501. PubMed ID: 1656189
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
    Pommier Y, Orr A, Kohn KW, Riou JF.
    Cancer Res; 1992 Jun 01; 52(11):3125-30. PubMed ID: 1317259
    [Abstract] [Full Text] [Related]

  • 5. Characterization of topoisomerase I and II activities in nuclear extracts during callogenesis in immature embryos of Zea mays.
    Carballo M, Giné R, Santos M, Puigdomènech P.
    Plant Mol Biol; 1991 Jan 01; 16(1):59-70. PubMed ID: 1653630
    [Abstract] [Full Text] [Related]

  • 6. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
    Woessner RD, Chung TD, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK.
    Cancer Res; 1990 May 15; 50(10):2901-8. PubMed ID: 2159365
    [Abstract] [Full Text] [Related]

  • 7. Overproduction of topoisomerase II in an ataxia telangiectasia fibroblast cell line: comparison with a topoisomerase II-overproducing hamster cell mutant.
    Davies SM, Harris AL, Hickson ID.
    Nucleic Acids Res; 1989 Feb 25; 17(4):1337-51. PubMed ID: 2537956
    [Abstract] [Full Text] [Related]

  • 8. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T, René B, Le Mée S, Lambert B, Saucier JM, Markovits J, Jacquemin-Sablon H, Jacquemin-Sablon A.
    Cancer Res; 1999 Oct 01; 59(19):4927-36. PubMed ID: 10519406
    [Abstract] [Full Text] [Related]

  • 9. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A, Tornaletti S, Stefanini M, Evans HH, Ricanati M, Astaldi Ricotti GC, Pedrini AM.
    Carcinogenesis; 1993 Sep 01; 14(9):1759-63. PubMed ID: 8403196
    [Abstract] [Full Text] [Related]

  • 10. In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in c-myc proto-oncogene.
    Riou JF, Vilarem MJ, Larsen CJ, Multon E, Riou GF.
    NCI Monogr; 1987 Sep 01; (4):41-7. PubMed ID: 2819730
    [Abstract] [Full Text] [Related]

  • 11. Interactions of Drosophila DNA topoisomerase II with left-handed Z-DNA in supercoiled minicircles.
    Glikin GC, Jovin TM, Arndt-Jovin DJ.
    Nucleic Acids Res; 1991 Dec 01; 19(25):7139-44. PubMed ID: 1662808
    [Abstract] [Full Text] [Related]

  • 12. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei.
    Gromova II, Thomsen B, Razin SV.
    Proc Natl Acad Sci U S A; 1995 Jan 03; 92(1):102-6. PubMed ID: 7816796
    [Abstract] [Full Text] [Related]

  • 13. Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
    Tan KB, Mattern MR, Boyce RA, Hertzberg RP, Schein PS.
    NCI Monogr; 1987 Jan 03; (4):95-8. PubMed ID: 2819739
    [Abstract] [Full Text] [Related]

  • 14. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC, Camacho-Carranza R.
    Rev Latinoam Microbiol; 1995 Jan 03; 37(3):291-304. PubMed ID: 8850348
    [Abstract] [Full Text] [Related]

  • 15. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
    Rene B, Fosse P, Khelifa T, Jacquemin-Sablon A, Bailly C.
    Mol Pharmacol; 1996 Feb 03; 49(2):343-50. PubMed ID: 8632768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.